GP Stakes Investing: How Blue Owl, Petershill, and Wafra Buy Into PE Managers

By Jeff Barnes, MBA | Angel Investors Network | August 3, 2026

TL;DR: A small group of specialized funds now buys 10-20% minority stakes in private equity and hedge fund management companies, collecting a permanent share of management fees and carried interest. Blue Owl's Dyal Capital division is targeting $13 billion for its sixth flagship fund. Goldman Sachs's Petershill unit sought $5 billion for its fifth fund in February 2026. This article explains the mechanics, the players, why GPs sell, and the risks investors should understand before buying in.

What GP Stakes Investing Is: The Basic Mechanics

A private equity firm has two revenue streams: management fees and carried interest. Management fees are typically 1.5-2% of committed capital per year, paid regardless of fund performance. Carried interest is 20% of profits above the hurdle rate, paid when investments are realized. Together, these make the management company, the legal entity that runs the fund, a valuable business in its own right.

GP stakes funds buy minority ownership in that management company, not in the underlying portfolio. When Blue Owl's Dyal Capital purchases a 15% stake in a mid-market buyout firm managing $8 billion in AUM, Dyal collects 15% of that firm's management fee income and 15% of whatever carried interest the firm earns on future funds. The underlying portfolio companies are irrelevant to the transaction. Dyal owns part of the toll booth, not the traffic.

The transaction is structured as a direct purchase of GP entity equity. Sellers are typically the founding partners of the management company. The stake buyer pays a negotiated multiple of fee-related earnings, with the current market range sitting at 10-15x FRE. On a firm generating $50 million annually in management fees with $30 million in FRE, a 15x multiple on a 15% stake implies a purchase price in the range of $67.5 million. The GP retains operational control. The stake buyer gets board observer rights and a perpetual income stream.

This is distinct from secondaries transactions, where investors buy LP positions in existing PE funds at a discount. For context on how the secondaries market operates, see our explainer on the secondaries market's record 2026 volumes. GP stakes investing operates at the management company level, upstream of the fund itself.

The income profile appeals to certain institutional investors because management fees are contractually fixed and recur annually. Carry is variable and back-ended. A GP stakes fund collects both, which produces a blended cash flow that is more predictable than a direct PE fund investment while still carrying exposure to performance.

The Major Players and Their Fund Sizes

Four firms dominate the institutional GP stakes market.

Blue Owl Capital / Dyal Capital. Dyal Capital Partners was founded in 2011 and acquired by Blue Owl in 2021 as part of a three-way SPAC merger. It is now the GP Solutions division of Blue Owl. The division's sixth flagship fund is targeting $13 billion, which would make it the largest GP stakes vehicle ever raised. Blue Owl's model involves buying stakes in established, multi-fund managers with proven track records and durable AUM. Their portfolio has included stakes in firms such as HPS Investment Partners, Vista Equity Partners, and KKR's credit business.

Petershill (Goldman Sachs). Petershill Partners was originally incubated inside Goldman Sachs Asset Management and later listed on the London Stock Exchange in 2021. By 2026, Goldman took the vehicle private. It was delisted from the LSE in 2026 and is now raising Petershill Fund V with a $5 billion target. The delisting reflects a broader industry view that public market valuations failed to capture the asset class's full worth. Petershill has historically targeted mid-to-large alternative managers globally, including stakes in Accel-KKR and Clearlake Capital.

Bonaccord Capital Partners (P10). Bonaccord operates inside P10, a publicly traded alternative asset manager. Bonaccord raised $1.6 billion for its latest GP stakes fund in January 2025. The Aberdeen/Bonaccord platform manages approximately $86 billion in AUM overall, with $22 billion specifically in GP stakes mandates. Bonaccord focuses on smaller and mid-market PE, credit, and real assets managers, a different segment of the market than Blue Owl's megafund targets.

Wafra. Wafra is the alternative investment arm of Kuwait's Public Institution for Social Security. It has been an active GP stakes buyer since the mid-2010s, with known stakes in firms including Benefit Street Partners and other credit managers. Wafra operates as both a direct GP stakes investor and a strategic capital partner, sometimes providing balance sheet support alongside the equity stake.

CAZ Investments. CAZ is a Houston-based registered investment advisor that has built a platform allowing high-net-worth and family office investors to access GP stakes on a direct basis. CAZ's model is central to the LP disintermediation trend reshaping the market.

Why GPs Sell: What It Signals About a Management Company

Founders of successful PE firms face a structural problem. Their wealth is entirely illiquid. It sits in management company equity, in GP commit obligations, and in unrealized carry. A founder running a $5 billion fund has built enormous economic value but cannot access it without selling the firm outright, which most founders refuse to do, or bringing in a GP stakes buyer.

Selling 15-20% to Dyal or Petershill solves the liquidity problem without surrendering control. The founder monetizes a portion of built equity at a market multiple while continuing to run the firm. Estate planning becomes manageable. Retirement becomes an option rather than a forced event.

Succession planning is a second driver. Many mid-market PE firms were built by one or two founding partners whose departure would destabilize the organization. A GP stakes sale forces the firm to articulate its succession plan as a condition of the transaction. Buyers conduct extensive due diligence on organizational depth. Firms that cannot demonstrate bench strength below the founding generation struggle to attract GP stakes capital.

The third driver is balance sheet. As PE firms move into credit, infrastructure, and real assets alongside traditional buyout, they need capital to co-invest alongside their own funds. GP co-investment has become a competitive differentiator for fundraising: LPs want to see GPs putting their own money to work. A GP stakes sale provides the capital needed to meet those co-invest obligations without depleting partner capital accounts. Understanding how PE management fee economics interact with this dynamic is useful; our piece on management fee offsets in private equity covers that mechanic in detail.

What does a GP stakes sale signal? It is not a distress signal. Firms that attract Dyal or Petershill capital are generally performing. The selection process is rigorous; buyers reject most prospects. A completed GP stakes transaction signals that an independent third party conducted institutional due diligence and concluded the management company is a durable business worth paying 10-15x FRE to own. For LPs already invested in that manager's funds, a GP stakes sale can be read as validation of the manager's quality.

Why LPs Are Cutting Out the Middleman and Going Direct

The traditional path into GP stakes was to invest in a GP stakes fund, paying Dyal or Petershill their management fee and carry, which then invested in individual management companies. Sophisticated LPs have recognized this as an expensive structure. They pay two layers of fees: one to the GP stakes fund, one indirectly through AUM drag to the underlying PE manager.

The response has been LP disintermediation. Large family offices and institutional investors now seek direct GP stakes transactions, bypassing the fund-of-funds structure entirely. Aberdeen's Bonaccord partnered with CAZ Investments specifically to bring direct GP stakes access to family offices and high-net-worth investors, allowing them to co-invest alongside Bonaccord's institutional mandates. This structure reduces fee drag significantly.

CAZ's platform is particularly notable because it extends GP stakes access below the typical institutional minimum. Family offices that could not meet a $10-25 million minimum for a dedicated GP stakes fund can now participate in individual transactions at lower thresholds. This mirrors the broader trend of GP-led structures pushing into the wealth channel, a shift covered in our analysis of NAV loans and private equity portfolio financing, another product originally designed for institutions now reaching private clients.

The rationale for going direct is also informational. A direct GP stakes investor develops deep knowledge of the management company's operations, personnel, and fund performance. That knowledge is valuable beyond the GP stakes investment itself: it informs allocation decisions across the investor's entire PE portfolio. An LP who co-owns 3% of a mid-market buyout firm's management company has better visibility into that firm's pipeline, talent, and strategic direction than an LP investing solely through the fund.

Risks: GP Underperformance, Key-Man Exposure, and Valuation Multiples

The GP stakes category carries risks that are specific to its structure and should not be underestimated.

GP underperformance. Management fees are contractually fixed during a fund's investment period, typically 5-7 years. A manager that fails to raise a successor fund sees those fees disappear. A GP stakes investor who purchased a stake at 12x FRE is left holding equity in a management company with no active fund and therefore no FRE. The carried interest component vanishes entirely if the portfolio underperforms the hurdle rate. GP stakes investors are buying the operator's future trajectory, not just today's income statement.

Key-man risk. GP stakes buyers conduct deep due diligence on organizational depth, but smaller PE firms remain heavily dependent on one or two senior partners. The departure of a founding partner, whether through retirement, death, or a competitor poaching, can trigger key-man provisions in fund documents that allow LPs to suspend capital calls. That suspension directly impairs the management company's fee stream. GP stakes buyers typically negotiate protections around key-man events, including rights to exit the stake at a pre-agreed valuation, but those protections do not eliminate the economic damage.

Valuation multiples. The 10-15x FRE range that defines current market pricing reflects favorable conditions: a long period of low interest rates, strong institutional demand for alternatives, and rapid AUM growth across the PE industry. AUM growth has slowed in 2025-2026 as fundraising has become more competitive. If FRE multiples compress to 8-10x, a plausible scenario if alternative AUM growth stalls or interest rate alternatives become more attractive, GP stakes investors who purchased at 14x face mark-to-market losses. The asset class is illiquid. There is no public market for these minority stakes, and secondary sales require buyer agreement and are infrequent.

Minority discount and governance. GP stakes buyers hold minority positions with no operational control. Board observer rights do not translate into board authority. If a management company makes poor strategic decisions, launching a fund strategy that fails to raise capital or expanding into geographies where they lack expertise, the GP stakes investor has limited recourse beyond negotiated contractual protections. The buyer is structurally subordinate to the founding partners on every operational question.

Regulatory risk. GP stakes investments sit at the intersection of PE regulation, broker-dealer rules, and investment adviser regulations. SEC scrutiny of fee disclosure in the alternatives industry has increased since 2024. Management companies that face regulatory sanctions can see fundraising impaired and AUM decline, directly hitting the fee revenue the GP stakes investor purchased.

These are not reasons to avoid the asset class. They are reasons to underwrite it carefully, concentrate capital in managers with demonstrated multi-fund track records, and price the purchase multiple conservatively relative to the market clearing level. The firms collecting the most GP stakes capital — Blue Owl's Dyal at $13 billion, Petershill at $5 billion — are betting that institutional demand for durable fee streams will outrun those risks. The next several years will test that bet.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.